Estellés A

No ORCID on file · 13 papers in corpus
observational 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.11.036

OBJECTIVE: To define the microRNA (miRNA) profile and its relationship with cytokines content in peritoneal fluid (PF) from endometriosis patients. DESIGN: Case-control study. SETTING: University hospital, research institute. PATIENT(S):…

review 2015
Thrombosis research ·doi:10.1016/s0049-3848(15)50439-8

miRNAs function as important regulators of a wide range of cellular processes, such as angiogenesis and fibrinolysis, by postranscriptional modulation of gene expression. We present a review on the role of miRNAs and angiogenesis in endomet…

lab-animal 2015
Human Reproduction ·doi:10.1093/humrep/dev204

STUDY QUESTION: Could peritoneal fluid (PF) from patients with endometriosis alter the microRNA (miRNA) expression profile in endometrial and endometriotic cells from patients? SUMMARY ANSWER: PF from patients with endometriosis modifies t…

observational 2014
Human Reproduction ·doi:10.1093/humrep/deu019

STUDY QUESTION: Could an aberrant microRNA (miRNA) expression profile be responsible for the changes in the angiogenic and fibrinolytic states observed in endometriotic lesions? SUMMARY ANSWER: This study revealed characteristic miRNA expr…

lab-animal 2013
PloS one ·doi:10.1371/journal.pone.0062370

UNLABELLED: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent gynecological diseases. It has been suggested that modifications of both endometrial and peritoneal factors could be implicate…

other 2011
Human Reproduction ·doi:10.1093/humrep/der025

BACKGROUND: Endometriosis is a common, multifactorial disease in which angiogenesis may be involved in the growth of endometrium outside the uterus. microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and p…

lab-animal 2009
Human Reproduction ·doi:10.1093/humrep/dep419

BACKGROUND: Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent benign gynaecological diseases. It has been suggested that both endometrial and peritoneal factors, related to angiogenesis an…

review 2008
Current medicinal chemistry ·doi:10.2174/092986708783955455

The fibrinolytic system includes a broad spectrum of proteolytic enzymes with physiological and pathophysiological functions in several processes, such as haemostatic balance, tissue remodeling, tumor invasion, angiogenesis and reproduction…

observational 2008
Thrombosis research ·doi:10.1016/j.thromres.2008.02.010

INTRODUCTION: Endometriosis is a benign gynecologic disease with a high prevalence. It is a multifactorial and polygenic entity in which the fibrinolytic system may be implicated. The objective of this study was to evaluate the plasminogen …

observational 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.08.079

OBJECTIVE: To analyze three functional vascular endothelial growth factor (VEGF) polymorphisms (-460C/T, +405G/C, and 936C/T) in women with and without endometriosis and their correlation with VEGF expression in endometrial tissue and perit…

observational 2007
Human Reproduction ·doi:10.1093/humrep/dem149

BACKGROUND: Endometriosis is a highly prevalent, benign disease in which the angiogenic, fibrinolytic and metalloproteinase (MMP) systems may be implicated. The objective of this study is to analyse mRNA expression and protein levels of sev…

other 2004
Human Reproduction ·doi:10.1093/humrep/deh571

BACKGROUND: The plasminogen activator (PA) and matrix metalloproteinase (MMP) systems are implicated in the establishment of endometriosis. The mechanisms by which these systems are involved in the pathogenesis of this disease are not well …

observational 2003
Human Reproduction ·doi:10.1093/humrep/deg300

BACKGROUND: Endometriosis is considered a benign disease that has the ability to invade normal tissue. As in neoplastic growth, local extracellular proteolysis may take place. The aim of this study is to analyse several components of the pl…